Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid

Acta Physiologica Scandinavica

Volumn 175, Issue 1, 2002, Pages 45-53

  Erhardt, S ^a   Engberg, G ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

A10; Achizophrenia; Burst activity; D cycloserine; Dopamine; Kynurenic acid; MK 801; PNU 156561A

Indexed keywords

CYCLOSERINE; DIZOCILPINE; DOPAMINE; ENZYME INHIBITOR; GLYCINE; KETAMINE; KYNURENIC ACID; KYNURENINE 3 MONOOXYGENASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; PHENCYCLIDINE; PNU 156561A; PSYCHEDELIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; CELL ACTIVITY; CELL ASSAY; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; ELECTROPHYSIOLOGY; MALE; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SCHIZOPHRENIA; VENTRAL TEGMENTUM;

ACTION POTENTIALS; ANIMALS; ANTIMETABOLITES; BUTYRATES; CYCLOSERINE; DIZOCILPINE MALEATE; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; KYNURENIC ACID; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; VENTRAL TEGMENTAL AREA;

EID: 0036096937     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201X.2002.00962.x     Document Type: Article

References (61)

1. From the cover: Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
2. Ultrastructural localization of tyrosine hydroxylase in the rat ventral tegmental area: Relationship between immunolabeling density and neuronal associations
3. Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: Effects of median forebrain bundle stimulation frequency, stimulation pattern, and dopamine autoreceptors
4. Burst firing of mesolimbic dopamine neurons is inhibited by somatodendritic application of kynurenate
5. Burst stimulation of the medial fore brain bundle selectively increase Fos-like immunoreactivity in the limbic fore brain of the rat
6. Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle
7. Excitotoxin lesions suggest an aspartergic projection from rat medial prefrontal cortex to ventral tegmental area
8. Technique for collecting cerebrospinal fluid in the cisterna magna of non-anesthetized rats
9. Modulation of extracellular kynurenic acid content by excitatory amino acids in primary cultures of rat astrocytes
10. Evidence for a GABAergic projections from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat
11. Evidence that non-NMDA receptors are involved in the excitatory pathway from the pedunculopontine region to nigrostriatal dopaminergic neurons
12. Activation of nigral dopamine neurons by the selective GABA (B)-receptor antagonist SCH 50911
13. Nicotine induced excitation of locus coeruleus neurons is blocked by elevated levels of endogenous kynurenic acid
14. GABAB receptor mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo
15. Pharmacologically elevated levels of kynurenic acid prevents nicotine-induced activation of nigral dopamine neurons
16. Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons
17. Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
18. Mesocorticolimbic dopamine systems and reward
19. Distribution of glutamate decarboxylase, choline acetyltransferase, and aromatic amino acid decarboxylase in the basal ganglia of normal and operated rats. Evidence for striatopallidal, striatoentopeduncular, and striatonigral GABAergic fibers
20. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: Comparison to competitive NMDA antagonists
21. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry
22. The control of firing pattern in nigral dopamine neurons: Single spike firing
23. The control of firing pattern in nigral dopamine neurons: Burst firing
24. Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro
25. Brain-specific modulation of kynurenic acid synthesis in the rat
26. The excitatory amino acid antagonist kynurenate induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo
27. Quantification of kynurenic acid in cerebrospinal fluid: Effects of systemic and central L-kynurenine administration
28. Recent advances in the phencyclidine model of schizophrenia
29. Burst firing in dopamine neurons induced by N-methyl-D-aspartate: Role of electrogenic sodium pump
30. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
31. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia
32. Mesocorticolimbic dopaminergic network: Functional and regulatory roles
33. NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers
34. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics
35. Effects of frequency and pattern of medial forebrain bundle stimulation on caudate dialysate dopamine and serotonin
36. Presence of kynurenic acid in the mammalian brain
37. Pharmacologically induced cessation of burst activity in nigral dopamine neurons; significance for the terminal dopamine efflux
38. Iontophoretically administered drugs acting at the N-methyl-D-aspartate receptor modulate burst firing in A9 dopamine neurons in the rat
39. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: Electrophysiological, biochemical and behavioral characterization
40. Dopaminergic control of kynurenate levels and N-methyl-D-aspartate toxicity in the developing rat striatum
41. Cerebral kynurenines in schizophrenia: A post-mortem study
42. GABAergic nerve terminals decreases in the substantia nigra following hemitransections of the striatonigral and pallidonigral pathways
43. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: Electrophysiological data
44. Electrophysiological properties of mouse dopamine neurons: In vivo and in vitro studies
45. Quantitative differences in the effects of de novo produced and exogenous kynurenic acid in rat brain slices
46. Electrophysiological effects of exogenous and endogenous kynurenic acid in the rat brain: Studies in vivo and in vitro
47. Regulation of substantia nigra pars reticulata neuronal activity by excitatory amino acids
48. Kynurenic acid, a potential pathogen in brain disorders
49. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: An anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin
50. Evidence for the presence of N-methyl-D-aspartate receptors in the ventral tegmental area of the rat: An electrophysiological in vitro study
51. (R,S)-3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats
52. Differential actions of serotonin, mediated by 5-HT1B and 5-HT2c receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro
53. Neuropharmacology of quinolinic and kynurenic acids
54. Cerebral synthesis and release of kynurenic acid: An endogenous antagonist of excitatory amino acid receptors
55. Identification and quantification of kynurenic acid in human brain tissue
56. Biochemical evidence for gamma-aminobutyrate containing fibers from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat
57. Dopaminergic neurons in the rat ventral tegmental area; I. Identification and characterization
58. The variability of central neural activity in a sensory system and its implification for the central reflection of sensory events
59. Presynaptic inhibition preferentially reduces in NMDA receptor-mediated component of transmission in rat midbrain dopamine neurons
60. Effects of phencyclidine, MK-801 and 1,3-di(2-tolyl)guanidine on non-dopaminergic midbrain neurons